In prostate cancer, TNK2 participates in a feed-forward epigenetic circuit involving ACK1/pY88-H4/WDR5/MLL2/AR and is necessary for malignant cancer (Mahajan et al., 2017). Here, AR is linked to prostate carcinoma.